SGRY
NasdaqSurgery Partners, Inc.
Healthcare · Services-General Medical & Surgical Hospitals, Nec
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$2.2B
2021
$2.5B
2022
$2.7B
2023
$3.1B
2024
$3.3B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$3.3B
Net Income$98.9M
Gross Profit—
Oper Income$389.5M
EPS (dil)$-0.61
Rev/sh$25.30
FCF/sh$1.50
Book/sh$23.94
Gross M—
Oper M11.8%
Profit M3.0%
FCF M5.9%
ROE3.2%
ROA1.2%
ROIC5.0%
R&D/Rev—
Rev Y/Y6.2%
Rev 3Y CAGR9.2%
EPS Y/Y54.1%
EPS 3Y CAGR—
FCF 3Y CAGR35.7%
Payout—
Div/sh—
Shs Chg Y/Y+0.9%
Current Ratio1.87
Quick Ratio1.71
Debt/Eq1.19
Int Coverage—
Net Debt$3.5B
Total Debt$3.7B
Cash & Eq$239.9M
Total Assets$8.1B
Oper CF$274.3M
Capex$78.7M
Free CF$195.6M
Buybacks$0
Equity$3.1B
Liabilities—
Shs Outstand0.13B
SectorHealthcare
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.5B | $2.7B | $3.1B | $3.3B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $302.2M | $345.2M | $328.0M | $348.8M | $389.5M |
| Net Income | $70.7M | $87.0M | $135.3M | $12.5M | $98.9M |
| Diluted EPS | $-1.12 | $-0.59 | $-0.09 | $-1.33 | $-0.61 |
| Operating Cash Flow | $87.1M | $158.8M | $293.8M | $300.1M | $274.3M |
| Free Cash Flow | $29.5M | $78.2M | $205.0M | $209.7M | $195.6M |
COMMUNITY · $SGRY0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.